Patents by Inventor Martin Luber
Martin Luber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9744314Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: GrantFiled: August 27, 2014Date of Patent: August 29, 2017Assignee: PARI Pharma GMBHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Patent number: 9717867Abstract: In a first aspect, the invention relates to a method for operating an aerosol inhalation device (10), comprising the steps of transporting a certain amount of an aerosol to a desired location outside said device (10) and vibrating the transported aerosol when it has reached said desired location. In a second aspect, the invention relates to an aerosol inhalation device (10) comprising a pump (1) for flowing a certain amount of an aerosol to a desired location outside the device (10), a vibrator (2) for vibrating the transported aerosol in a vibration mode and a control configured to actuate the vibrator (2) for vibrating the flowed aerosol only when it has reached said desired location.Type: GrantFiled: February 27, 2009Date of Patent: August 1, 2017Assignees: PARI GmbH Spezialisten für effektive Inhalation, PARI Pharma GmbHInventors: Martin Luber, Andreas Boehm, Uwe Schuschnig, Axel Krüner
-
Patent number: 9046092Abstract: The compressor includes two compression spaces (1, 5) separate from one another, one of which serves to generate the continuous pressure medium flow for the generation of a basic aerosol flow, whereas the other is used to generate the pressure variations. The shared compression device (4), for example a piston, is moved in a pendulum motion by a drive (7) so that a gas is conveyed through the first compression space and pressure variations are imposed upon a gas volume via the second compression space. The drive is disposed in a compression space, use advantageously being made of the space volume available that may if necessary be made use of by the compressor. In a preferred embodiment the drive (7) is located in the compression space (5) that is used to generate the pressure variations.Type: GrantFiled: March 15, 2007Date of Patent: June 2, 2015Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Andreas Boehm, Martin Luber
-
Publication number: 20140366872Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 litres per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: ApplicationFiled: August 27, 2014Publication date: December 18, 2014Inventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Patent number: 8852557Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterized in that it exhibits a low effective flow rate of less than about 5 liters per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: GrantFiled: August 29, 2008Date of Patent: October 7, 2014Assignee: PARI Pharma GmbHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Publication number: 20140137858Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.Type: ApplicationFiled: January 27, 2014Publication date: May 22, 2014Applicant: PARI GmbH Spezialisten für effektive InhalationInventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
-
Patent number: 8671933Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.Type: GrantFiled: March 8, 2007Date of Patent: March 18, 2014Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
-
Patent number: 8347878Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.Type: GrantFiled: April 7, 2008Date of Patent: January 8, 2013Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Uwe Schuschnig, Martin Luber, Wolfgang Achtzehner
-
Patent number: 8342171Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurised gas, preferably pressurised air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomised is therefore substantially atomised only in the inhalation phases.Type: GrantFiled: January 25, 2012Date of Patent: January 1, 2013Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Andreas Boehm, Martin Luber
-
Publication number: 20120125326Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurised gas, preferably pressurised air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomised is therefore substantially atomised only in the inhalation phases.Type: ApplicationFiled: January 25, 2012Publication date: May 24, 2012Applicant: PARI GmbH Spezialisten fuer effektive InhalationInventors: Andreas Boehm, Martin Luber
-
Publication number: 20120085344Abstract: In a first aspect, the invention relates to a method for operating an aerosol inhalation device (10), comprising the steps of transporting a certain amount of an aerosol to a desired location outside said device (10) and vibrating the transported aerosol when it has reached said desired location. In a second aspect, the invention relates to an aerosol inhalation device (10) comprising a pump (1) for flowing a certain amount of an aerosol to a desired location outside the device (10), a vibrator (2) for vibrating the transported aerosol in a vibration mode and a control configured to actuate the vibrator (2) for vibrating the flowed aerosol only when it has reached said desired location.Type: ApplicationFiled: February 27, 2009Publication date: April 12, 2012Applicants: PARI Pharma GmbH, PARI GmbH Spezialisten fuer effektive InhalationInventors: Martin Luber, Andreas Boehm, Uwe Schusching, Axel Kruener
-
Patent number: 8113194Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurized gas, preferably pressurized air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomized is therefore substantially atomized only in the inhalation phases.Type: GrantFiled: May 15, 2006Date of Patent: February 14, 2012Assignee: PARI GmbH Spezialisten für effektive InhalationInventors: Andreas Boehm, Martin Luber
-
Patent number: 8006698Abstract: The invention regards a therapeutic aerosol device in which a main aerosol flow, which is generated with the help of a compressed gas and is supplied to one of the nostrils of a user, is superimposed by pressure fluctuations. The superimposition of the pressure fluctuations occurs directly at one of the two nostrils of the user. A flow resistance is provided in the other nostril.Type: GrantFiled: January 8, 2007Date of Patent: August 30, 2011Assignee: PARI GmbH Spezialisten fuer effektive InhalationInventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
-
Patent number: 7980247Abstract: A therapeutic aerosol device in which an aerosol generated by a nebulising device is supplied through a nosepiece to a patient's nostril so that the main aerosol flow supplied is able to emerge from the other nostril. The main aerosol flow is superimposed by pressure fluctuations. In order to guarantee that, due to the pressure fluctuation, aerosol is transported to the paranasal sinuses, a low resistance device is provided in the other nostril.Type: GrantFiled: August 27, 2003Date of Patent: July 19, 2011Assignee: PARI GmbH Spezialisten fuer effektive InhalationInventors: Andreas Boehm, Christiane Horn, Martin Luber, Markus Mornhinweg, Titus Selzer, Johann Zimmermann
-
Publication number: 20100316576Abstract: A pharmaceutical aerosol is disclosed which is suitable for delivering an active compound to the mucosa of the nose, the osteomeatal complex or a paranasal sinus. The pressure of the aerosol is not constant, but pulsates at a frequency from about 10 to 90 Hz. The aerosol is further characterised in that it exhibits a low effective flow rate of less than about 5 litres per minute. The aerosol is, inter alia, suitable for the prevention, management, or treatment of a disease, symptom, or condition affecting the nose or the paranasal sinuses, such as acute and chronic sinusitis.Type: ApplicationFiled: August 29, 2008Publication date: December 16, 2010Applicant: PARI PHARMA GMBHInventors: Manfred Keller, Uwe Schuschnig, Johann Zimmermann, Martin Luber, Andreas Böhm
-
Publication number: 20090301473Abstract: To increase the efficacy of atomizer nozzles operating with compressed gas, an atomizer device for inhalation therapy appliances includes means for delivering a compressed gas, in particular compressed air; means for supplying a fluid that is to be atomized, in particular a therapeutic liquid; several compressed gas outlet openings from which a delivered compressed gas emerges; and several fluid outlet openings from which the fluid to be atomized emerges on account of the emerging compressed gas. The atomizer device includes at least three compressed gas outlet openings arranged in a row, and one of the compressed gas outlet openings is in each case assigned at least two fluid outlet openings which, together with the associated compressed gas outlet opening, form an atomizer nozzle.Type: ApplicationFiled: March 8, 2007Publication date: December 10, 2009Applicant: PARI GMBH SPEZIALISTEN FUER EFFEKTIVE INHALATIONInventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger
-
Publication number: 20090217923Abstract: A breath-controlled inhalation therapy device includes an obturation mechanism, obturating a nozzle opening through which a pressurized gas, preferably pressurized air, is issued when the device is in operation. An actuation mechanism actuates the obturation mechanism only in the exhalation phases of the respiration cycle of a patient. The fluid to be atomized is therefore substantially atomized only in the inhalation phases.Type: ApplicationFiled: May 15, 2006Publication date: September 3, 2009Applicant: PARI GmbH Spezialisten fuer effektive InhalationInventors: Andreas Boehm, Martin Luber
-
Publication number: 20080251068Abstract: Aerosol therapy device comprising a nebuliser (10) for generating an aerosol and forming an aerosol flow, a first nosepiece (11) for introducing the aerosol flow into one of the two nostrils (12) of a user, a pressure fluctuation source for generating a pressure fluctuation (DS), a second nosepiece (14) for introducing the pressure fluctuation into the other of the two nostrils (15) of the user in order to superimpose the pressure fluctuation and the aerosol flow, and a sensor system comprising a first pressure sensor (19) for detecting the signal of the pressure fluctuation that arrives at the first nosepiece (11), and an evaluation means (18) that concludes the degree of closure of the velum of the user based on the signal.Type: ApplicationFiled: April 7, 2008Publication date: October 16, 2008Applicant: PARI GmbH Spezialisten fuer effektive InhalationInventors: Uwe Schuschnig, Martin Luber, Wolfgang Achtzehner
-
Publication number: 20070215150Abstract: The compressor comprises two compression spaces (1, 5) separate from one another, one of which serves to generate the continuous pressure medium flow for the generation of a basic aerosol flow, whereas the other is used to generate the pressure variations. The shared compression means (4), for example a piston, is moved in a pendulum motion by a drive (7) so that a gas is conveyed through the first compression space and pressure variations are imposed upon a gas volume via the second compression space. The drive is disposed in a compression space, use advantageously being made of the space volume available that may if necessary be made use of by the compressor. In a preferred embodiment the drive (7) is located in the compression space (5) that is used to generate the pressure variations.Type: ApplicationFiled: March 15, 2007Publication date: September 20, 2007Applicant: Pari GmbH Spezialisten fur effektive InhalationInventors: Andreas Boehm, Martin Luber
-
Publication number: 20070181133Abstract: The invention regards a therapeutic aerosol device in which a main aerosol flow, which is generated with the help of a compressed gas and is supplied to one of the nostrils of a user, is superimposed by pressure fluctuations. The superimposition of the pressure fluctuations occurs directly at one of the two nostrils of the user. A flow resistance is provided in the other nostril.Type: ApplicationFiled: January 8, 2007Publication date: August 9, 2007Applicant: Pari GmbH Spezialisten fuer effektive inhalationInventors: Andreas Boehm, Martin Luber, Sven Rosenbeiger